Interaction of a non-peptide agonist with angiotensin II AT(1) receptor mutants
Autor(a) principal: | |
---|---|
Data de Publicação: | 2002 |
Outros Autores: | , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UNIFESP |
Texto Completo: | http://dx.doi.org/10.1139/Y02-058 http://repositorio.unifesp.br/handle/11600/26837 |
Resumo: | To identify residues of the rat AT(1A) angiotensin II receptor involved with signal transduction and binding of the non-peptide agonist L-162,313 (5,7-dimethyl-2-ethyl-3-[[4-[2(n-butyloxycarbonylsulfonamido)-5-isobutyl-3-thienyl]phenyl]methyl]imidazol[4,5,6]-pyridine) we have performed ligand binding and inositol phosphate turnover assays in COS-7 cells transiently transfected with the wild-type and mutant forms of the receptor. Mutant receptors bore modifications in the extracellular region: T88H, Y92H, G196I, G196W, and D278E. Compound L-162,313 displaced [I-125]-Sar(1),Leu(8)-AngII from the mutants G196I and G196W with IC50 values similar to that of the wild-type. the affinity was, however, slightly affected by the D278E mutation and more significantly by the T88H and Y92H mutations. in inositol phosphate turnover assays, the ability of L-162,313 to trigger the activation cascade was compared with that of angiotensin II. These assays showed that the G196W mutant reached a relative maximum activation exceeding that of the wild-type receptor; the efficacy was slightly reduced in the G196I mutant and further reduced in the T88H, Y92H, and D278E mutants. Our data suggest that residues of the extracellular domain of the AT(1) receptor are involved in the binding of the non-peptide ligand, or in a general receptor activation phenomenon that involves conformational modifications for a preferential binding of agonists or antagonists. |
id |
UFSP_8ac1b179600d2b014e53a87dcdc292f7 |
---|---|
oai_identifier_str |
oai:repositorio.unifesp.br/:11600/26837 |
network_acronym_str |
UFSP |
network_name_str |
Repositório Institucional da UNIFESP |
repository_id_str |
3465 |
spelling |
Interaction of a non-peptide agonist with angiotensin II AT(1) receptor mutantsangiotensinreceptorGPCRnon-peptide agonisttransductionTo identify residues of the rat AT(1A) angiotensin II receptor involved with signal transduction and binding of the non-peptide agonist L-162,313 (5,7-dimethyl-2-ethyl-3-[[4-[2(n-butyloxycarbonylsulfonamido)-5-isobutyl-3-thienyl]phenyl]methyl]imidazol[4,5,6]-pyridine) we have performed ligand binding and inositol phosphate turnover assays in COS-7 cells transiently transfected with the wild-type and mutant forms of the receptor. Mutant receptors bore modifications in the extracellular region: T88H, Y92H, G196I, G196W, and D278E. Compound L-162,313 displaced [I-125]-Sar(1),Leu(8)-AngII from the mutants G196I and G196W with IC50 values similar to that of the wild-type. the affinity was, however, slightly affected by the D278E mutation and more significantly by the T88H and Y92H mutations. in inositol phosphate turnover assays, the ability of L-162,313 to trigger the activation cascade was compared with that of angiotensin II. These assays showed that the G196W mutant reached a relative maximum activation exceeding that of the wild-type receptor; the efficacy was slightly reduced in the G196I mutant and further reduced in the T88H, Y92H, and D278E mutants. Our data suggest that residues of the extracellular domain of the AT(1) receptor are involved in the binding of the non-peptide ligand, or in a general receptor activation phenomenon that involves conformational modifications for a preferential binding of agonists or antagonists.Universidade Federal de São Paulo, Escola Paulista Med, Dept Biophys, BR-04023062 São Paulo, BrazilUniv Copenhagen, Panum Inst, Mol Pharmacol Lab, DK-2200 Copenhagen, DenmarkUniversidade Federal de São Paulo, Escola Paulista Med, Dept Biophys, BR-04023062 São Paulo, BrazilWeb of ScienceNatl Research Council CanadaUniversidade Federal de São Paulo (UNIFESP)Univ CopenhagenCosta-Neto, Claudio MiguelMiyakawa, Ayumi A.Pesquero, João Bosco [UNIFESP]Oliveira, LaerteHjorth, Siv A.Schwartz, Thue W.Paiva, Antonio Cechelli de Mattos [UNIFESP]2016-01-24T12:33:21Z2016-01-24T12:33:21Z2002-05-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion413-417http://dx.doi.org/10.1139/Y02-058Canadian Journal of Physiology and Pharmacology. Ottawa: Natl Research Council Canada, v. 80, n. 5, p. 413-417, 2002.10.1139/Y02-0580008-4212http://repositorio.unifesp.br/handle/11600/26837WOS:000175428800008engCanadian Journal of Physiology and Pharmacologyinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2016-01-24T10:33:21Zoai:repositorio.unifesp.br/:11600/26837Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652016-01-24T10:33:21Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false |
dc.title.none.fl_str_mv |
Interaction of a non-peptide agonist with angiotensin II AT(1) receptor mutants |
title |
Interaction of a non-peptide agonist with angiotensin II AT(1) receptor mutants |
spellingShingle |
Interaction of a non-peptide agonist with angiotensin II AT(1) receptor mutants Costa-Neto, Claudio Miguel angiotensin receptor GPCR non-peptide agonist transduction |
title_short |
Interaction of a non-peptide agonist with angiotensin II AT(1) receptor mutants |
title_full |
Interaction of a non-peptide agonist with angiotensin II AT(1) receptor mutants |
title_fullStr |
Interaction of a non-peptide agonist with angiotensin II AT(1) receptor mutants |
title_full_unstemmed |
Interaction of a non-peptide agonist with angiotensin II AT(1) receptor mutants |
title_sort |
Interaction of a non-peptide agonist with angiotensin II AT(1) receptor mutants |
author |
Costa-Neto, Claudio Miguel |
author_facet |
Costa-Neto, Claudio Miguel Miyakawa, Ayumi A. Pesquero, João Bosco [UNIFESP] Oliveira, Laerte Hjorth, Siv A. Schwartz, Thue W. Paiva, Antonio Cechelli de Mattos [UNIFESP] |
author_role |
author |
author2 |
Miyakawa, Ayumi A. Pesquero, João Bosco [UNIFESP] Oliveira, Laerte Hjorth, Siv A. Schwartz, Thue W. Paiva, Antonio Cechelli de Mattos [UNIFESP] |
author2_role |
author author author author author author |
dc.contributor.none.fl_str_mv |
Universidade Federal de São Paulo (UNIFESP) Univ Copenhagen |
dc.contributor.author.fl_str_mv |
Costa-Neto, Claudio Miguel Miyakawa, Ayumi A. Pesquero, João Bosco [UNIFESP] Oliveira, Laerte Hjorth, Siv A. Schwartz, Thue W. Paiva, Antonio Cechelli de Mattos [UNIFESP] |
dc.subject.por.fl_str_mv |
angiotensin receptor GPCR non-peptide agonist transduction |
topic |
angiotensin receptor GPCR non-peptide agonist transduction |
description |
To identify residues of the rat AT(1A) angiotensin II receptor involved with signal transduction and binding of the non-peptide agonist L-162,313 (5,7-dimethyl-2-ethyl-3-[[4-[2(n-butyloxycarbonylsulfonamido)-5-isobutyl-3-thienyl]phenyl]methyl]imidazol[4,5,6]-pyridine) we have performed ligand binding and inositol phosphate turnover assays in COS-7 cells transiently transfected with the wild-type and mutant forms of the receptor. Mutant receptors bore modifications in the extracellular region: T88H, Y92H, G196I, G196W, and D278E. Compound L-162,313 displaced [I-125]-Sar(1),Leu(8)-AngII from the mutants G196I and G196W with IC50 values similar to that of the wild-type. the affinity was, however, slightly affected by the D278E mutation and more significantly by the T88H and Y92H mutations. in inositol phosphate turnover assays, the ability of L-162,313 to trigger the activation cascade was compared with that of angiotensin II. These assays showed that the G196W mutant reached a relative maximum activation exceeding that of the wild-type receptor; the efficacy was slightly reduced in the G196I mutant and further reduced in the T88H, Y92H, and D278E mutants. Our data suggest that residues of the extracellular domain of the AT(1) receptor are involved in the binding of the non-peptide ligand, or in a general receptor activation phenomenon that involves conformational modifications for a preferential binding of agonists or antagonists. |
publishDate |
2002 |
dc.date.none.fl_str_mv |
2002-05-01 2016-01-24T12:33:21Z 2016-01-24T12:33:21Z |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://dx.doi.org/10.1139/Y02-058 Canadian Journal of Physiology and Pharmacology. Ottawa: Natl Research Council Canada, v. 80, n. 5, p. 413-417, 2002. 10.1139/Y02-058 0008-4212 http://repositorio.unifesp.br/handle/11600/26837 WOS:000175428800008 |
url |
http://dx.doi.org/10.1139/Y02-058 http://repositorio.unifesp.br/handle/11600/26837 |
identifier_str_mv |
Canadian Journal of Physiology and Pharmacology. Ottawa: Natl Research Council Canada, v. 80, n. 5, p. 413-417, 2002. 10.1139/Y02-058 0008-4212 WOS:000175428800008 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Canadian Journal of Physiology and Pharmacology |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
413-417 |
dc.publisher.none.fl_str_mv |
Natl Research Council Canada |
publisher.none.fl_str_mv |
Natl Research Council Canada |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UNIFESP instname:Universidade Federal de São Paulo (UNIFESP) instacron:UNIFESP |
instname_str |
Universidade Federal de São Paulo (UNIFESP) |
instacron_str |
UNIFESP |
institution |
UNIFESP |
reponame_str |
Repositório Institucional da UNIFESP |
collection |
Repositório Institucional da UNIFESP |
repository.name.fl_str_mv |
Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP) |
repository.mail.fl_str_mv |
biblioteca.csp@unifesp.br |
_version_ |
1814268399314796544 |